blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1047443

EP1047443 - METHODS AND COMPOSITIONS FOR ENHANCING COGNITIVE FUNCTION USING MORPHOGENIC PROTEINS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  31.10.2003
Database last updated on 20.09.2024
Most recent event   Tooltip31.10.2003Withdrawal of applicationpublished on 17.12.2003  [2003/51]
Applicant(s)For all designated states
Curis, Inc.
61 Moulton Street
Cambridge, MA 02138 / US
[2001/19]
Former [2000/44]For all designated states
CREATIVE BIOMOLECULES, INC.
45 South Street
Hopkinton, MA 01748 / US
Inventor(s)01 / CHARETTE, Marc, F.
18 Ellicott Street
Needham, MA 02192 / US
[2000/44]
Representative(s)MacLean, Martin Robert, et al
Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2003/20]MacLean, Martin Robert, et al
Mathys & Squire 100 Gray's Inn Road
London WC1X 8AL / GB
Former [2000/44]Schlich, George William, et al
Mathys & Squire 100 Gray's Inn Road
London WC1X 8AL / GB
Application number, filing date99903241.021.01.1999
[2000/44]
WO1999US01232
Priority number, dateUS1998001284623.01.1998         Original published format: US 12846
[2000/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9937320
Date:29.07.1999
Language:EN
[1999/30]
Type: A1 Application with search report 
No.:EP1047443
Date:02.11.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 29.07.1999 takes the place of the publication of the European patent application.
[2000/44]
Search report(s)International search report - published on:EP29.07.1999
ClassificationIPC:A61K38/18, A61K48/00
[2000/44]
CPC:
A61K38/1875 (EP,US); A61K48/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/44]
TitleGerman:METHODEN UND ZUSAMMENSETZUNGEN ZUR VERSTÄRKUNG KOGNITIVER FUNKTIONEN UNTER VERWENDUNG MORPHOGENER PROTEINE[2000/44]
English:METHODS AND COMPOSITIONS FOR ENHANCING COGNITIVE FUNCTION USING MORPHOGENIC PROTEINS[2000/44]
French:PROCEDES ET COMPOSITIONS POUR AMELIORER LA FONCTION COGNITIVE AU MOYEN DE PROTEINES MORPHOGENIQUES[2000/44]
Entry into regional phase22.08.2000National basic fee paid 
22.08.2000Designation fee(s) paid 
22.08.2000Examination fee paid 
Examination procedure23.08.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.08.2000Examination requested  [2000/44]
06.04.2001Despatch of a communication from the examining division (Time limit: M08)
16.10.2001Reply to a communication from the examining division
19.03.2002Despatch of a communication from the examining division (Time limit: M06)
29.07.2002Reply to a communication from the examining division
23.10.2003Application withdrawn by applicant  [2003/51]
Divisional application(s)EP03023804.2  / EP1398039
Fees paidRenewal fee
19.12.2000Renewal fee patent year 03
21.01.2002Renewal fee patent year 04
20.01.2003Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US5652118  (OZKAYNAK ENGIN [US], et al) [X] 1-26 * column 3, line 4 - line 30 * * column 4, line 18 - column 5, line 23 * * column 6, line 31 - column 7, line 14 * * column 7, line 30 - column 8, line 21 * * column 8, line 43 - line 66 * * column 10, line 57 - line 62 * * column 13, line 49 - line 58 * * column 14, line 52 - line 56 * * column 15, line 8 - line 11 * * column 18, line 11 - line 29 * * column 32, line 15 - line 21 *;
 [DX]WO9403200  (CREATIVE BIOMOLECULES INC [US]) [DX] 1-25 * abstract * * page 2, line 29 - page 3, line 19 * * page 6, line 30 - page 7, line 15 * * page 8, line 4 - line 17 * * page 10, line 6 - page 17, line 4 * * page 17, line 27 - page 19, line 3 * * page 19, line 24 - line 26 * * page 20, line 21 - page 21, line 14 * * page 41, line 11 - line 25 * * page 42, line 27 - page 43, line 22 * * page 55, line 16 - line 26 * * page 59, line 21 - page 60, line 5 * * page 63, line 16 - page 65, line 28 * * page 68, line 14 - line 17 * * page 79, line 25 - page 81, line 15 * * page 82, line 1 - page 89, line 34 * * page 98, line 31 - page 99, line 12 * * claims 1-93 *;
 [X]WO9505846  (GENETICS INST [US], et al) [X] 1-10,12,14-19,21-26 * abstract * * page 1, line 10 - line 14 * * page 2, line 4 - page 3, line 3 * * page 3, line 22 - line 29 * * page 5, line 5 - line 15 * * page 5, line 26 - page 6, line 17 * * page 8, line 9 - line 16 * * claims 1-21 *;
 [DX]WO9734626  (CREATIVE BIOMOLECULES INC [US], et al) [DX] 1-24 * abstract * * page 1, line 5 - line 8 * * page 3, line 24 - page 8, line 2 * * page 11, line 5 - page 13, line 2 * * page 15, line 22 - line 30 * * page 16, line 20 - line 31 * * page 25, line 13 - page 28, line 5 * * page 28, line 13 - line 15 * * page 28, line 32 - page 29, line 5 * * claims 1-26 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.